Samsung Biologics 

Samsung Biologics operates as a biopharmaceutical division of Samsung, established to provide comprehensive contract development and manufacturing services. The company specializes in the production of drug substances and finished products, catering to the needs of pharmaceutical companies worldwide. Its services encompass a wide range of activities, including bioanalytical testing, which is crucial for ensuring the safety and efficacy of biopharmaceutical products. Samsung Biologics has positioned itself as a key player in the biopharmaceutical industry, leveraging advanced technologies and facilities to meet the growing demand for biologics. The company has invested significantly in expanding its manufacturing capabilities, which has allowed it to increase production capacity and enhance service offerings. This strategic focus on contract development and manufacturing has enabled Samsung Biologics to attract a diverse clientele, including both established pharmaceutical firms and emerging biotech companies seeking reliable partners for their product development needs. The biopharmaceutical sector is experiencing rapid growth, driven by advancements in biotechnology and an increasing number of biologic therapies entering the market. As a result, Samsung Biologics is well-positioned to capitalize on these trends, contributing to the overall growth of the biopharmaceutical industry and supporting the development of innovative therapies that address unmet medical needs.